AstraZeneca and GSK slide on Trump threats but analysts see positive catalysts ahead

  • Shares in AstraZeneca PLC (LSE:AZN) and GSK PLC (LSE:GSK, NYSE:GSK) were both down over 1% on Friday, but the shares are worth buying, analysts at Shore Capital said.  Blue-chip shares across London and Europe were lower on Friday, after Donald Trump scaled up his tariff rhetoric again.